Oric Pharmaceuticals (ORIC)
Oric Pharmaceuticals on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
15.4M
Short interest
settlement 2026-10-15
10.5
Days to cover
+0.7 days vs prior
48.1%
Short share of volume
2026-11-02
60,077
Fails to deliver
settlement 2026-10-13
Thu 12 Nov
Next earnings
estimated date
-$1.5M
Insider flow, 90 days
0 buys, 7 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ORIC is 15,422,384 shares, down 2,110,089 shares over the last month. Over the last 48 readings it ranged from 6,758,787 shares (31 July 2025) to 22,108,499 shares (30 June 2026). At the reported average volume of 1.5M shares a day that is 10.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/oric" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 15,422,384 | -5.5% | 1,468,518 | 10.50 |
| 2026-09-30 | 16,315,970 | -6.9% | 1,655,964 | 9.85 |
| 2026-09-15 | 17,532,473 | +1.5% | 1,234,100 | 14.21 |
| 2026-08-31 | 17,266,340 | -6.1% | 1,068,546 | 16.16 |
| 2026-08-14 | 18,392,742 | -15.7% | 1,677,499 | 10.96 |
| 2026-07-31 | 21,804,868 | -1.1% | 1,609,144 | 13.55 |
| 2026-07-15 | 22,053,046 | -0.3% | 1,630,521 | 13.53 |
| 2026-06-30 | 22,108,499 | +5.0% | 1,794,531 | 12.32 |
| 2026-06-15 | 21,057,176 | -4.0% | 2,042,965 | 10.31 |
| 2026-05-29 | 21,936,119 | -0.0% | 1,272,063 | 17.24 |
| 2026-05-15 | 21,944,065 | -0.3% | 1,426,015 | 15.39 |
| 2026-04-30 | 22,009,149 | +6.1% | 1,325,464 | 16.60 |
| 2026-04-15 | 20,741,008 | +7.2% | 3,653,244 | 5.68 |
| 2026-03-31 | 19,346,213 | -6.3% | 1,504,444 | 12.86 |
| 2026-03-13 | 20,653,722 | -5.2% | 1,715,293 | 12.04 |
| 2026-02-27 | 21,794,521 | -1.4% | 1,673,841 | 13.02 |
| 2026-02-13 | 22,095,837 | +2.1% | 1,154,966 | 19.13 |
| 2026-01-30 | 21,645,503 | +2.4% | 1,692,580 | 12.79 |
| 2026-01-15 | 21,138,063 | -1.6% | 1,956,863 | 10.80 |
| 2025-12-31 | 21,469,843 | +19.6% | 1,512,222 | 14.20 |
| 2025-12-15 | 17,956,700 | +2.2% | 1,324,573 | 13.56 |
| 2025-11-28 | 17,566,525 | +8.1% | 1,254,652 | 14.00 |
| 2025-11-14 | 16,253,539 | +4.9% | 1,071,253 | 15.17 |
| 2025-10-31 | 15,494,904 | +19.0% | 1,169,592 | 13.25 |
| 2025-10-15 | 13,020,257 | +15.8% | 1,723,770 | 7.55 |
| 2025-09-30 | 11,242,529 | +18.0% | 1,641,480 | 6.85 |
| 2025-09-15 | 9,528,668 | +16.6% | 1,086,635 | 8.77 |
| 2025-08-29 | 8,174,386 | +13.5% | 728,155 | 11.23 |
| 2025-08-15 | 7,202,705 | +6.6% | 772,089 | 9.33 |
| 2025-07-31 | 6,758,787 | -45.0% | 1,566,891 | 4.31 |
| 2025-07-15 | 12,290,002 | -2.3% | 629,456 | 19.52 |
| 2025-06-30 | 12,580,266 | -1.0% | 1,219,169 | 10.32 |
| 2025-06-13 | 12,712,072 | -4.8% | 1,368,005 | 9.29 |
| 2025-05-30 | 13,348,681 | +14.2% | 2,618,538 | 5.10 |
| 2025-05-15 | 11,686,545 | +4.4% | 585,554 | 19.96 |
| 2025-04-30 | 11,192,498 | -15.6% | 566,728 | 19.75 |
| 2025-04-15 | 13,255,542 | -12.2% | 941,389 | 14.08 |
| 2025-03-31 | 15,102,133 | +8.1% | 935,696 | 16.14 |
| 2025-03-14 | 13,969,650 | +3.2% | 497,632 | 28.07 |
| 2025-02-28 | 13,535,317 | +12.4% | 1,152,414 | 11.75 |
| 2025-02-14 | 12,039,954 | +15.2% | 2,128,000 | 5.66 |
| 2025-01-31 | 10,448,300 | -0.7% | 703,286 | 14.86 |
| 2025-01-15 | 10,517,970 | -8.0% | 828,822 | 12.69 |
| 2024-12-31 | 11,435,863 | +2.1% | 377,850 | 30.27 |
| 2024-12-13 | 11,205,474 | -0.8% | 245,984 | 45.55 |
| 2024-11-29 | 11,291,959 | -1.5% | 346,534 | 32.59 |
| 2024-11-15 | 11,461,558 | -1.6% | 486,866 | 23.54 |
| 2024-10-31 | 11,650,740 | -2.9% | 460,624 | 25.29 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of ORIC volume is 48.1%, up 15.9 points over the last five sessions. Over the last 30 readings it ranged from 21.9% (9 October 2026) to 81.0% (22 September 2026). The latest reading is in line with the 30-session average of 47.9%, on 373K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 179K | 373K | 48.1% | 402 |
| 2026-10-30 | 522K | 941K | 55.5% | 0 |
| 2026-10-29 | 125K | 230K | 54.3% | 0 |
| 2026-10-28 | 236K | 446K | 52.8% | 0 |
| 2026-10-27 | 554K | 2.4M | 23.2% | 30,668 |
| 2026-10-26 | 1.0M | 3.2M | 32.2% | 59,495 |
| 2026-10-23 | 283K | 639K | 44.3% | 0 |
| 2026-10-22 | 196K | 337K | 58.1% | 0 |
| 2026-10-21 | 224K | 756K | 29.6% | 0 |
| 2026-10-20 | 518K | 978K | 52.9% | 9,236 |
| 2026-10-19 | 284K | 419K | 67.8% | 0 |
| 2026-10-16 | 158K | 252K | 62.9% | 0 |
| 2026-10-15 | 331K | 512K | 64.6% | 705 |
| 2026-10-14 | 304K | 684K | 44.5% | 0 |
| 2026-10-13 | 177K | 450K | 39.4% | 0 |
| 2026-10-12 | 115K | 387K | 29.7% | 0 |
| 2026-10-09 | 115K | 526K | 21.9% | 0 |
| 2026-10-08 | 368K | 1.1M | 33.0% | 0 |
| 2026-10-07 | 122K | 267K | 45.5% | 0 |
| 2026-10-06 | 447K | 1.1M | 42.3% | 0 |
| 2026-10-05 | 174K | 473K | 36.7% | 0 |
| 2026-10-02 | 198K | 525K | 37.7% | 1,000 |
| 2026-10-01 | 182K | 745K | 24.4% | 21,062 |
| 2026-09-30 | 365K | 536K | 68.2% | 0 |
| 2026-09-29 | 227K | 385K | 59.2% | 38 |
| 2026-09-28 | 351K | 619K | 56.8% | 12,241 |
| 2026-09-25 | 958K | 1.5M | 62.3% | 0 |
| 2026-09-24 | 453K | 918K | 49.4% | 501 |
| 2026-09-23 | 398K | 688K | 57.8% | 0 |
| 2026-09-22 | 441K | 544K | 81.0% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in ORIC is 60,077 shares, up 59,407 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (28 April 2026) to 469,138 shares (30 July 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 60,077 | $11.81 | $710K |
| 2026-09-25 | 670 | $13.18 | $9K |
| 2026-09-24 | 5,200 | $13.33 | $69K |
| 2026-09-08 | 205,262 | $12.86 | $2.6M |
| 2026-08-31 | 11 | $13.24 | $146 |
| 2026-08-24 | 11,308 | $14.20 | $161K |
| 2026-08-21 | 43 | $13.88 | $597 |
| 2026-08-20 | 4,500 | $14.65 | $66K |
| 2026-08-11 | 57,375 | $13.62 | $781K |
| 2026-08-06 | 3,750 | $12.93 | $48K |
| 2026-07-30 | 469,138 | $11.28 | $5.3M |
| 2026-07-28 | 1,829 | $12.02 | $22K |
| 2026-07-27 | 6,500 | $12.10 | $79K |
| 2026-07-13 | 32,711 | $10.85 | $355K |
| 2026-07-09 | 1,031 | $10.90 | $11K |
| 2026-07-08 | 9,629 | $10.88 | $105K |
| 2026-07-06 | 2,429 | $11.64 | $28K |
| 2026-07-02 | 66 | $10.89 | $719 |
| 2026-07-01 | 7,731 | $10.83 | $84K |
| 2026-06-30 | 8,553 | $10.16 | $87K |
| 2026-06-29 | 10,975 | $9.53 | $105K |
| 2026-06-25 | 7,253 | $9.43 | $68K |
| 2026-06-18 | 2,206 | $8.63 | $19K |
| 2026-06-16 | 4,396 | $8.40 | $37K |
| 2026-05-27 | 4 | $8.54 | $34 |
| 2026-05-22 | 4,650 | $8.46 | $39K |
| 2026-05-01 | 94,102 | $9.88 | $930K |
| 2026-04-28 | 1 | $10.19 | $10 |
| 2026-04-24 | 450 | $10.43 | $5K |
| 2026-04-15 | 4,200 | $10.53 | $44K |
Insider trades
SEC Form 4, newest first. JSONInsiders at ORIC reported 7 open-market sells worth $1.5M in the last 90 days and no open-market buys. Latest filing: Piscitelli Dominic (Chief Financial Officer) on 2026-10-20.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-20 | Piscitelli Dominic | Chief Financial Officer | Sell | 14K | $13.53 | $189K | 70K |
| 2026-10-20 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 14K | $4.36 | $61K | 84K |
| 2026-10-01 | Heyman Richard A. | Director | Sell | 3K | $12.91 | $41K | 203K |
| 2026-10-01 | Heyman Richard A. | Director | Sell | 4K | $12.91 | $45K | 38K |
| 2026-10-01 | Heyman Richard A. | Director | Exercise or conversion | 4K | $1.60 | $6K | 42K |
| 2026-09-28 | Piscitelli Dominic | Chief Financial Officer | Sell | 13K | $13.53 | $181K | 70K |
| 2026-09-28 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 13K | $4.36 | $58K | 83K |
| 2026-09-24 | Piscitelli Dominic | Chief Financial Officer | Sell | 500 | $13.51 | $7K | 70K |
| 2026-09-24 | Piscitelli Dominic | Chief Financial Officer | Sell | 100 | $13.50 | $1K | 70K |
| 2026-09-24 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 600 | $4.36 | $3K | 70K |
| 2026-08-26 | Piscitelli Dominic | Chief Financial Officer | Sell | 77K | $13.69 | $1.1M | 70K |
| 2026-08-26 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 25K | $6.00 | $150K | 147K |
| 2026-08-26 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 52K | $4.36 | $227K | 122K |
| 2026-07-24 | Heyman Richard A. | Director | Sell | 6K | $12.02 | $73K | 207K |
| 2026-07-24 | Heyman Richard A. | Director | Sell | 7K | $12.02 | $84K | 38K |
| 2026-07-24 | Heyman Richard A. | Director | Exercise or conversion | 4K | $1.60 | $6K | 45K |
| 2026-07-06 | Heyman Richard A. | Director | Sell | 300 | $12.00 | $4K | 213K |
| 2026-02-24 | Piscitelli Dominic | Chief Financial Officer | Sell | 52K | $13.51 | $703K | 68K |
| 2026-02-24 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 52K | $4.36 | $227K | 120K |
| 2026-01-16 | Heyman Richard A. | Director | Sell | 3K | $12.00 | $38K | 213K |
| 2026-01-16 | Heyman Richard A. | Director | Sell | 4K | $12.00 | $42K | 42K |
| 2025-12-16 | Piscitelli Dominic | Chief Financial Officer | Sell | 11K | $9.06 | $97K | 68K |
| 2025-12-16 | Multani Pratik S | Chief Medical Officer | Sell | 11K | $9.06 | $97K | 68K |
| 2025-12-16 | Chacko Jacob | PRESIDENT AND CEO | Sell | 33K | $9.06 | $302K | 582K |
| 2025-12-15 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 29K | $0.00 | $0 | 79K |
| 2025-12-15 | Multani Pratik S | Chief Medical Officer | Exercise or conversion | 29K | $0.00 | $0 | 79K |
| 2025-12-15 | Chacko Jacob | PRESIDENT AND CEO | Exercise or conversion | 84K | $0.00 | $0 | 615K |
| 2025-12-08 | Kunkel Lori Anne | Director | Exercise or conversion | 10K | $7.90 | $79K | 84K |
| 2025-12-04 | Kunkel Lori Anne | Director | Exercise or conversion | 6K | $3.75 | $21K | 74K |
| 2025-10-06 | Piscitelli Dominic | Chief Financial Officer | Sell | 11K | $14.52 | $160K | 48K |
| 2025-10-06 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 11K | $4.36 | $48K | 59K |
| 2025-10-06 | Chacko Jacob | PRESIDENT AND CEO | Sell | 37K | $12.32 | $462K | 531K |
| 2025-10-03 | Heyman Richard A. | Director | Exercise or conversion | 1K | $3.75 | $5K | 45K |
| 2025-10-03 | Heyman Richard A. | Director | Exercise or conversion | 31K | $1.60 | $50K | 44K |
| 2025-10-01 | Chacko Jacob | PRESIDENT AND CEO | Sell | 53K | $12.05 | $639K | 569K |
| 2025-09-30 | Chacko Jacob | PRESIDENT AND CEO | Sell | 35K | $12.01 | $415K | 622K |
| 2025-09-22 | Chacko Jacob | PRESIDENT AND CEO | Sell | 125K | $10.80 | $1.3M | 656K |
| 2025-07-01 | Piscitelli Dominic | Chief Financial Officer | Sell | 20K | $10.05 | $201K | 48K |
| 2025-06-24 | Piscitelli Dominic | Chief Financial Officer | Sell | 32K | $10.50 | $341K | 68K |
| 2025-06-23 | You Angie | Director | Buy | 1K | $9.43 | $13K | 28K |
| 2025-06-23 | Piscitelli Dominic | Chief Financial Officer | Sell | 450 | $10.01 | $5K | 101K |
| 2025-06-23 | Piscitelli Dominic | Chief Financial Officer | Sell | 584 | $10.00 | $6K | 101K |
| 2025-06-20 | You Angie | Director | Buy | 27K | $9.39 | $250K | 27K |
| 2025-06-12 | Piscitelli Dominic | Chief Financial Officer | Sell | 300 | $10.00 | $3K | 102K |
| 2025-06-11 | Piscitelli Dominic | Chief Financial Officer | Sell | 1K | $10.00 | $13K | 104K |
| 2025-06-11 | Piscitelli Dominic | Chief Financial Officer | Sell | 2K | $10.01 | $17K | 102K |
| 2025-06-10 | Piscitelli Dominic | Chief Financial Officer | Sell | 324 | $10.00 | $3K | 105K |
| 2025-06-09 | Piscitelli Dominic | Chief Financial Officer | Sell | 300 | $10.00 | $3K | 104K |
| 2025-06-06 | Piscitelli Dominic | Chief Financial Officer | Sell | 3K | $10.01 | $26K | 104K |
| 2025-03-03 | Kunkel Lori Anne | Director | Exercise or conversion | 28K | $3.75 | $104K | 48K |
| 2025-03-03 | Kunkel Lori Anne | Director | Exercise or conversion | 21K | $6.33 | $130K | 69K |
| 2024-12-16 | Chacko Jacob | PRESIDENT AND CEO | Sell | 25K | $8.28 | $204K | 779K |
| 2024-12-16 | Multani Pratik S | Chief Medical Officer | Sell | 9K | $8.28 | $73K | 47K |
| 2024-12-16 | Piscitelli Dominic | Chief Financial Officer | Sell | 9K | $8.28 | $73K | 107K |
| 2024-12-15 | Chacko Jacob | PRESIDENT AND CEO | Exercise or conversion | 67K | $0.00 | $0 | 803K |
| 2024-12-15 | Multani Pratik S | Chief Medical Officer | Exercise or conversion | 24K | $0.00 | $0 | 56K |
| 2024-12-15 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 24K | $0.00 | $0 | 116K |
| 2024-06-03 | Kunkel Lori Anne | Director | Exercise or conversion | 21K | $3.75 | $77K | 21K |
| 2024-03-06 | Chacko Jacob | PRESIDENT AND CEO | Sell | 40K | $16.21 | $648K | 729K |
| 2024-02-07 | Chacko Jacob | PRESIDENT AND CEO | Sell | 26K | $12.30 | $320K | 769K |
| 2024-02-06 | Chacko Jacob | PRESIDENT AND CEO | Sell | 14K | $12.12 | $169K | 795K |
| 2023-12-15 | Chacko Jacob | President and CEO | Sell | 15K | $8.58 | $125K | 809K |
| 2023-12-15 | Chacko Jacob | President and CEO | Exercise or conversion | 39K | $0.00 | $0 | 823K |
| 2023-12-15 | Piscitelli Dominic | Chief Financial Officer | Sell | 5K | $8.58 | $45K | 84K |
| 2023-12-15 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 14K | $0.00 | $0 | 89K |
| 2023-12-15 | Multani Pratik S | Chief Medical Officer | Sell | 5K | $8.59 | $45K | 24K |
| 2023-12-15 | Multani Pratik S | Chief Medical Officer | Exercise or conversion | 14K | $0.00 | $0 | 29K |
| 2023-07-11 | Chacko Jacob | President and CEO | Sell | 5K | $8.01 | $41K | 781K |
| 2023-07-10 | Chacko Jacob | President and CEO | Sell | 11K | $8.01 | $84K | 786K |
| 2023-07-05 | Chacko Jacob | President and CEO | Sell | 4K | $8.01 | $35K | 796K |
| 2023-06-26 | Chacko Jacob | President and CEO | Sell | 20K | $8.03 | $161K | 801K |
| 2022-12-15 | Chacko Jacob | President and CEO | Sell | 6K | $3.07 | $19K | 817K |
| 2022-12-15 | Piscitelli Dominic | Chief Financial Officer | Sell | 2K | $3.08 | $7K | 67K |
| 2022-12-15 | Multani Pratik S | Chief Medical Officer | Sell | 2K | $3.07 | $7K | 7K |
| 2022-12-15 | Chacko Jacob | President and CEO | Exercise or conversion | 17K | $0.00 | $0 | 823K |
| 2022-12-15 | Chacko Jacob | President and CEO | Sell | 6K | $3.25 | $19K | 817K |
| 2022-12-15 | Piscitelli Dominic | Chief Financial Officer | Exercise or conversion | 6K | $0.00 | $0 | 70K |
| 2022-12-15 | Piscitelli Dominic | Chief Financial Officer | Sell | 2K | $3.25 | $7K | 67K |
| 2022-12-15 | Multani Pratik S | Chief Medical Officer | Exercise or conversion | 6K | $0.00 | $0 | 10K |
| 2022-12-15 | Multani Pratik S | Chief Medical Officer | Sell | 2K | $3.25 | $7K | 7K |
| 2022-05-13 | Chacko Jacob | President and CEO | Buy | 76K | $2.82 | $215K | 803K |
| 2022-05-12 | Chacko Jacob | President and CEO | Buy | 69K | $2.75 | $191K | 727K |
| 2022-05-11 | Chacko Jacob | President and CEO | Buy | 305K | $2.90 | $883K | 657K |
| 2022-03-31 | Piscitelli Dominic | Chief Financial Officer | Buy | 60K | $5.36 | $322K | 60K |
| 2022-03-25 | Chacko Jacob | President and CEO | Buy | 50K | $4.54 | $227K | 353K |
| 2022-03-24 | Chacko Jacob | President and CEO | Buy | 43K | $5.03 | $216K | 303K |
| 2022-03-23 | Chacko Jacob | President and CEO | Buy | 257K | $4.98 | $1.3M | 260K |
| 2021-11-16 | COLUMN GROUP II, LP | 10% owner | Other transaction | 87K | $0.00 | $0 | 87K |
| 2021-11-16 | COLUMN GROUP II, LP | 10% owner | Other transaction | 288K | $0.00 | $0 | 288K |
| 2021-11-16 | COLUMN GROUP II, LP | TenPercentOwner | Other transaction | 1.2M | $0.00 | $0 | 3.6M |
| 2021-11-16 | COLUMN GROUP II, LP | TenPercentOwner | Other transaction | 288K | $0.00 | $0 | 0 |
| 2021-11-16 | COLUMN GROUP II, LP | TenPercentOwner | Other transaction | 74 | $0.00 | $0 | 74 |
| 2021-11-16 | COLUMN GROUP II, LP | TenPercentOwner | Other transaction | 87K | $0.00 | $0 | 103K |
| 2021-11-12 | COLUMN GROUP II, LP | TenPercentOwner | Exercise or conversion | 17K | $16.00 | $266K | 17K |
| 2021-09-15 | Chacko Jacob | President and CEO | Sell | 4K | $25.06 | $94K | 3K |
| 2021-09-15 | Heyman Richard A. | Director | Sell | 682 | $25.03 | $17K | 216K |
| 2021-09-14 | Chacko Jacob | President and CEO | Sell | 4K | $25.05 | $111K | 6K |
| 2021-09-14 | Heyman Richard A. | Director | Sell | 706 | $25.05 | $18K | 217K |
| 2021-09-13 | Chacko Jacob | President and CEO | Sell | 3K | $25.02 | $70K | 11K |
| 2021-09-13 | Heyman Richard A. | Director | Sell | 601 | $25.01 | $15K | 218K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON8 Form 144 notices on file for ORIC worth $4.7M at the prices reported; 0 in the last 90 days worth $0. Latest: Dominic Piscitelli filed on 2026-02-24 to sell 52,000 shares ($702K) from 2026-02-24.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-02-24 | Dominic PiscitelliOfficer | 52K | $702K | 0.052% | 2026-02-24 | J.P. Morgan Securities LLC |
| 2026-01-16 | Richard A, HeymanDirector | 6K | $77K | 0.007% | 2026-01-16 | J.P. Morgan Securities LLC |
| 2026-01-16 | Richard A, HeymanDirector | 7K | $84K | 0.007% | 2026-01-16 | J.P. Morgan Securities LLC |
| 2025-12-16 | Piscitelli DominicOfficer | 11K | $97K | 0.011% | 2025-12-16 | E-Trade Financial Corporation |
| 2025-12-16 | Multani Pratik SOfficer | 11K | $97K | 0.011% | 2025-12-16 | E-Trade Financial Corporation |
| 2025-12-16 | Chacko JacobOfficer, Director | 33K | $302K | 0.034% | 2025-12-16 | E-Trade Financial Corporation |
| 2025-10-06 | Dominic PiscitelliOfficer | 50K | $725K | 0.051% | 2025-10-06 | J.P. Morgan Securities LLC |
| 2025-09-22 | Jacob ChackoDirector, Officer | 250K | $2.6M | 0.257% | 2025-09-22 | J.P. Morgan Securities LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON9 holders report 5% or more of ORIC in their latest filing, all on Schedule 13G (passive). The largest reported stake is HALVORSEN OLE ANDREAS at 7.8% of the class (8,264,607 shares), filed 2026-05-15 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-15 | 13G/Ano. 2 | Venrock Healthcare Capital Partners EG, L.P.partnership | 4.3M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Venrock Healthcare Capital Partners III, L.P.partnership | 4.3M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | VHCP Co-Investment Holdings III, LLCother entity | 4.3M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | VHCP Management III, LLCother entity | 4.3M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | VHCP Management EG, LLCother entity | 4.3M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Nimish Shahindividual | 4.3M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Bong Y. Kohindividual | 4.3M | 4.2% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Steven A. Cohenindividual | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Point72 Capital Advisors, Inc.corporation | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Point72 Asset Management, L.P.partnership | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | HALVORSEN OLE ANDREASindividual | 8.3M | 7.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | VIKING GLOBAL INVESTORS LPpartnership | 8.3M | 7.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Viking Global Opportunities Parent GP LLCother entity | 8.3M | 7.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Shabet Rose Sharonindividual | 8.3M | 7.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Viking Global Opportunities Portfolio GP LLCother entity | 5.3M | 5.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Viking Global Opportunities Illiquid Investments Sub-Master LPpartnership | 5.3M | 5.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Viking Global Opportunities GP LLCother entity | 5.3M | 5.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Viking Global Opportunities Drawdown Portfolio GP LLCother entity | 3.0M | 2.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Viking Global Opportunities Drawdown GP LLCother entity | 3.0M | 2.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Viking Global Opportunities Drawdown (Aggregator) LPpartnership | 3.0M | 2.8% | 2026-03-31 |
| 2026-05-15 | 13G | T. Rowe Price Associates, Inc.investment adviser | 5.4M | 5.4% | 2026-03-31 |
| 2026-01-21 | 13G | BlackRock, Inc.parent holding company | 5.5M | 5.6% | 2025-12-31 |
| 2025-11-17 | 13G/Ano. 3 | Peter Svennilsonindividual | 3.6M | 3.7% | 2025-09-30 |
| 2025-11-17 | 13G/Ano. 3 | David V Goeddelindividual | 3.6M | 3.7% | 2025-09-30 |
| 2025-11-17 | 13G/Ano. 3 | The Column Group II GP, LPpartnership | 3.5M | 3.6% | 2025-09-30 |
| 2025-11-17 | 13G/Ano. 3 | The Column Group II, LPpartnership | 3.5M | 3.6% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 3 | Alkeon Capital Management LLCinvestment adviser, other entity | 4.5M | 4.6% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 3 | Panayotis D. Sparaggisparent holding company, individual | 4.5M | 4.6% | 2025-09-30 |
13F holders
Tracked managers holding ORIC at their latest 13F. JSON6 of the 30 tracked managers held ORIC at their latest 13F, $118.7M in total at quarter-end prices. Viking Global Investors is the largest at $55.5M (0.2% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Viking Global Investors | 2026-06-30 | 5.1M | $55.5M | 0.16% | -698K |
| Citadel Advisors | 2026-06-30 | 2.6M | $28.1M | 0.00% | +173K |
| D. E. Shaw & Co. | 2026-06-30 | 1.6M | $17.1M | 0.01% | +1.5M |
| Millennium Management | 2026-06-30 | 698K | $7.6M | 0.00% | +664K |
| Two Sigma Investments | 2026-06-30 | 604K | $6.5M | 0.00% | new |
| AQR Capital Management | 2026-06-30 | 359K | $3.9M | 0.00% | +189K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Oric Pharmaceuticals in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Oric Pharmaceuticals (ORIC), SEC CIK 1796280, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-02-24.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-15.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-03.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-20.JSON and CSV
- Company record
- EDGAR filing index for CIK 1796280Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of ORIC is sold short?
15,422,384 shares were held short at the 2026-10-15 settlement, 10.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ORIC's daily short volume?
On 2026-11-02, 179,175 of the 372,721 ORIC shares reported to FINRA were sold short, 48.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ORIC have fails to deliver?
The SEC's latest file shows 60,077 ORIC shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are ORIC insiders buying or selling?
Insiders at ORIC reported 7 open-market sells worth $1.5M in the last 90 days and no open-market buys. Latest filing: Piscitelli Dominic (Chief Financial Officer) on 2026-10-20.
Have ORIC insiders filed to sell?
8 Form 144 notices on file for ORIC worth $4.7M at the prices reported; 0 in the last 90 days worth $0. Latest: Dominic Piscitelli filed on 2026-02-24 to sell 52,000 shares ($702K) from 2026-02-24.
Who owns 5% or more of ORIC?
9 holders report 5% or more of ORIC in their latest filing, all on Schedule 13G (passive). The largest reported stake is HALVORSEN OLE ANDREAS at 7.8% of the class (8,264,607 shares), filed 2026-05-15 for an event on 2026-03-31.
Which tracked 13F managers own ORIC?
6 of the 30 tracked 13F managers held ORIC shares at their latest filing, $118.7M in all. The largest: Andreas Halvorsen's Viking Global Investors (5.1M shares, $55.5M), Ken Griffin's Citadel Advisors (2.6M shares, $28.1M), D. E. Shaw & Co. (1.6M shares, $17.1M), Izzy Englander's Millennium Management (698K shares, $7.6M), Two Sigma Investments (604K shares, $6.5M), Cliff Asness's AQR Capital Management (359K shares, $3.9M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.